Innate Pharma Financials
| IPHYF Stock | USD 1.28 0.00 0.00% |
Innate |
Understanding current and past Innate Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innate Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Innate Pharma's assets may result in an increase in income on the income statement.
Innate Pharma Stock Summary
Innate Pharma competes with Northwest Biotherapeutics, and Geron. Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company was incorporated in 1999 and is headquartered in Marseille, France. Innate Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 213 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | FR0010331421 |
| Business Address | 117, Avenue de |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.innate-pharma.com |
| Phone | 33 4 30 30 30 30 |
| Currency | USD - US Dollar |
Innate Pharma Key Financial Ratios
There are many critical financial ratios that Innate Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Innate Pharma reports annually and quarterly.| Return On Equity | -0.17 | |||
| Return On Asset | -0.043 | |||
| Number Of Employees | 213 | |||
| Beta | 0.33 | |||
| Z Score | 12.0 |
Innate Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Innate Pharma's current stock value. Our valuation model uses many indicators to compare Innate Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innate Pharma competition to find correlations between indicators driving Innate Pharma's intrinsic value. More Info.Innate Pharma is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innate Pharma's earnings, one of the primary drivers of an investment's value.Innate Pharma Systematic Risk
Innate Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innate Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Innate Pharma correlated with the market. If Beta is less than 0 Innate Pharma generally moves in the opposite direction as compared to the market. If Innate Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innate Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innate Pharma is generally in the same direction as the market. If Beta > 1 Innate Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Innate Pharma November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Innate Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innate Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innate Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Innate Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innate Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 45.38 |
Complementary Tools for Innate Pink Sheet analysis
When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |